Kevin Sean Murnane

17PUBLICATIONS
54CO-AUTHORS
Biologically active moleculesPharmacogenomicsCounselling psychologyToxicology (incl. clinical toxicology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 04, 2026
Next-Generation Psychedelic Drug Development.

|Aug 26, 2026
Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases.

|Aug 01, 2026
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.

|Mar 19, 2026
Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.

Bo Jarrett Wood, M Frances Vest, Catharine Carfagno

|Jul 31, 2025
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage.

Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri

|Jul 24, 2025
96-h methamphetamine self-administration elicits striatal dopamine depletion in male and female rats: a model of binge-like use.

Bo Jarrett Wood, Ethan D Brackett, Nicole M Hall

Pageof 3

Frequent Collaborators

2 joint publications

Alan D Kaye

2 joint publications

Elyse M Cornett

2 joint publications

Amber N Edinoff

1 joint publications

Charles D Nichols